Sign in with Google. Opens in new tab
ENTITY
Bayer

Bayer (BAYN GY)

26
Analysis
Health CareGermany
Bayer AG produces and markets healthcare and agricultural products. The Company manufactures products that include aspirin, antibiotics, anti-infectives, cardiovascular, oncology, central nervous system drugs, over-the-counter medications, diagnostics, and animal health products, as well as crop protection products, plastics, and polyurethanes.
more
bullishBayer
25 Jun 2025 11:00

Bayer AG has reported its first quarter results for 2025

Bayer AG has reported its first quarter results for 2025, revealing a mixed performance across its business divisions amidst challenging...

Logo
236 Views
Share
12 Feb 2022 15:40

Insights from Data Mining Technical Publications - Microbes - Bacteriophages

Innovations are modifying and harnessing microbes for new  uses in agriculture, industry, and as potential new therapeutics to replace or...

Logo
358 Views
Share
bearishMacroeconomics
29 Aug 2023 18:22

The Energy Cable #35 – Are Monster Draws Ahead?

From supply to demand side weakness in 12 months. Key take aways: As opposed to last year, Germany is now seeing the demand side...

Logo
281 Views
Share
bearishSyngenta Group
12 Jul 2023 00:58

Syngenta Pre-IPO - The Negatives - Margins Remain Razor Thin and Parent on Sanction List

Syngenta Group (1844795D CH) is looking to raise around US$9.2bn in its upcoming China A-share IPO. In this note, we will talk about the not so...

Logo
407 Views
Share
bullishSyngenta Group
11 Jul 2023 01:43

Syngenta Pre-IPO - The Positives - Giant in the Agriculture Industry Set to Benefit from Policies

Syngenta Group (1844795D CH) is looking to raise around US$9.2bn in its upcoming China A-share IPO. In this note, we will talk about the positive...

Logo
524 Views
Share
x